Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Comcast Corporation (CMCSA) vs Cytokinetics Inc (CYTK) Price & Performance

Comcast CorporationTrade
Cytokinetics IncTrade

Price performance (Past 24H)

Key statistics

Comcast Corporation vs Cytokinetics Inc — how do they compare? Comcast Corporation trades at $25.63 (market cap $89.43B), while Cytokinetics Inc trades at $76.66 (market cap $10.78B). The key difference: Comcast Corporation is far larger — about 8.3× Cytokinetics Inc's market cap, and Comcast Corporation pays a 5.24% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.

CMCSACYTK
Market Cap
$89.43B$10.78B
Sector
MediaTechnology
52-Week High
$32.50$87.26
52-Week Low
$21.92$34.31
Enterprise Value
$172.15B$10.88B
Dividend Yield
5.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Comcast Corporation

No Aura AI signal available yet.

Cytokinetics Inc

Cytokinetics (CYTK) trades at $76.76, down 5.67% today, with a bearish technical signal and negative profitability metrics. Recent Q2 2026 earnings beat EPS estimates but missed on revenue, while the company's drug Myqorzo shows strong commercial uptake and regulatory approvals in the UK. Cash flow remains negative from operations, offset by financing activities.

The outlook is mixed: strong analyst buy ratings (97%) and a $111.14 price target suggest upside, but high cash burn, competitive pressures, and lack of profitability pose significant risks. Investment appeal hinges on successful drug commercialization and path to profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Comcast Corporation

Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to roughly 61 million U.S. homes and businesses, or nearly half of the country. About 56% of the homes in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC broadcast network, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is the dominant television provider in the U.K. and has invested heavily in exclusive and proprietary content to build this position. The firm is also the largest pay-television provider in Italy and has a presence in Germany and Austria.

Read more on CMCSA

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK